Myriad Genetics (MYGN) Q4 2021 Earnings

2NovConfirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-0.14
-0.05
0.03
0.12

Details

Expected EPS
-0.01
Actual EPS
-0.02
Surprise EPS
-0.01
Surprise Percent
+100%

Description

Myriad Genetics (MYGN) has reported earnings of -0.02 per share for Q4 2021.

0 Comments

Share your thoughts